Skip to content
Femasys Logo
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis

Category: Media

FDA grants IDE approval for FemBloc nonsurgical permanent birth control

Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million

Meet the metro Atlanta woman who invented a new permanent birth control

The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick

Femasys’ Roadmap for FemBloc in Europe

Suwanee company raising millions following approval of birth-control product

Transforming women’s health: The power of Femtech and minimally invasive solutions

Intratubal insemination: Another Option in Fertility Treatment

Femasys Offers a Fresh Take on Women’s Reproductive Healthcare

Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys

← older
newer →
About Femasys
  • Who We Are
  • Leadership
Investor Relations
  • Overview
  • News
  • Event & Presentations
  • Stock Info
  • Financials
  • Governance
  • Resources
Resources
  • Who We Are
  • Leadership
Contact Us
  • Contact Femasys
  • Join Us
Healthcare Professionals
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Patients
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Privacy Policy
Terms of Use
Patents
Accessibility
Order
Copyright © 2024 Femasys Inc.
FemaSeed, FemBloc, FemCath, FemCerv, and FemVue are registered trademarks of Femasys Inc.
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis